John Barkinge
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Cell death mechanisms and regulation 4
- Cancer therapeutics and mechanisms 1
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Radhika Gudi (5 shared papers)Fei Chu (3 shared papers)Prasad Kanteti (2 shared papers)Ravi Salgia (1 shared paper)Richard B. Jones (4 shared papers)Mark F. Ciaccio (3 shared papers)Chih‐Pin Chuu (3 shared papers)Florian Grebien (1 shared paper)
- Journals
- Molecular Cancer Research (1 paper)Journal of Carcinogenesis (1 paper)Molecular & Cellular Proteomics (1 paper)Nature Structural & Molecular Biology (1 paper)Journal of Environmental Pathology Toxicology and Oncology (1 paper)
- Partner nations
- United StatesTaiwanUnited Kingdom
In The Last Decade
John Barkinge
9 papers receiving 504 citations
Peers
Comparison fields: 5 of 71
- Oncology 203
- Radiology, Nuclear Medicine and Imaging 129
- Molecular Biology 328
- Immunology and Allergy 22
- Cancer Research 46
Countries citing papers authored by John Barkinge
This map shows the geographic impact of John Barkinge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Barkinge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Barkinge more than expected).
Fields of papers citing papers by John Barkinge
This network shows the impact of papers produced by John Barkinge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Barkinge. The network helps show where John Barkinge may publish in the future.
Co-authors
The 25 scholars most cited alongside John Barkinge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 198 | |
| 2 | 2010 | 128 | |
| 3 | 2012 | 49 | |
| 4 | 2004 | 39 | |
| 5 | 2006 | 30 | |
| 6 | 2008 | 24 | |
| 7 | 2014 | 16 | |
| 8 | 2009 | 16 | |
| 9 | 2009 | 15 |
About John Barkinge
John Barkinge is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 9 papers that have together received 515 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Phytochemicals and Medicinal Plants (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Cancer therapeutics and mechanisms (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Radiation Therapy and Dosimetry (1 paper). The work is most often cited by research in Oncology (203 citations), Radiology, Nuclear Medicine and Imaging (129 citations), Molecular Biology (328 citations), Immunology and Allergy (22 citations) and Cancer Research (46 citations). John Barkinge has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include Radhika Gudi, Fei Chu, Prasad Kanteti, Ravi Salgia, Richard B. Jones, Mark F. Ciaccio, Chih‐Pin Chuu, Florian Grebien, Oliver Hantschel and John Wojcik. Their work appears in journals such as Molecular Cancer Research, Journal of Carcinogenesis, Molecular & Cellular Proteomics, Nature Structural & Molecular Biology and Journal of Environmental Pathology Toxicology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.